Appointments

Rodney Dausch named VP of finance and CFO at Morphotek

Published in Gene Therapy Weekly, August 22nd, 2002

Morphotek, Inc., announced the appointment of Rodney Dausch as vice president and CFO.

Dausch has more than 30 years of experience in financial and operations management, most recently as executive vice president and chief operating officer for a publicly held biopharmaceutical company, where he also led its successful initial and follow-on public offerings as CFO.

"Rod brings with him an outstanding record of achievements in senior finance and administration positions at both private and publicly held biotechnology companies," said Nicholas C. Nicolaides, president and CEO. "His extensive operational skills and business networks will bring...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-08-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry